Workflow
P/B ratio
icon
Search documents
NNGRY vs. BWIN: Which Stock Is the Better Value Option?
ZACKS· 2025-03-18 16:40
Core Viewpoint - Investors in the Life Insurance sector should consider NN Group NV Unsponsored ADR (NNGRY) and The Baldwin Insurance Group (BWIN) for potential value opportunities [1] Valuation Metrics - NNGRY has a forward P/E ratio of 7.19, while BWIN has a forward P/E of 22.21 [5] - NNGRY's PEG ratio is 0.72, indicating a more favorable valuation compared to BWIN's PEG ratio of 1.04 [5] - NNGRY's P/B ratio is 0.66, significantly lower than BWIN's P/B of 4.73, suggesting NNGRY is undervalued relative to its book value [6] Analyst Outlook - NNGRY has a Zacks Rank of 1 (Strong Buy), indicating a positive earnings estimate revision trend, while BWIN has a Zacks Rank of 3 (Hold) [3] - The stronger estimate revision activity for NNGRY suggests a more favorable analyst outlook compared to BWIN [7] Value Grades - NNGRY has a Value grade of B, while BWIN has a Value grade of D, reflecting NNGRY's more attractive valuation metrics [6]
PYPL or MA: Which Is the Better Value Stock Right Now?
ZACKS· 2025-03-14 16:41
Investors interested in stocks from the Financial Transaction Services sector have probably already heard of Paypal (PYPL) and MasterCard (MA) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes co ...
BKEAY vs. NABZY: Which Stock Should Value Investors Buy Now?
ZACKS· 2025-03-13 17:09
Core Viewpoint - The Bank of East Asia Ltd. (BKEAY) is currently viewed as a more attractive investment option compared to National Australia Bank Ltd. (NABZY) for value investors seeking undervalued stocks [1][3][7] Valuation Metrics - BKEAY has a forward P/E ratio of 6.25, significantly lower than NABZY's forward P/E of 14.37 [5] - The PEG ratio for BKEAY is 0.80, indicating a favorable valuation in relation to its expected earnings growth, while NABZY's PEG ratio is much higher at 7.64 [5] - BKEAY's P/B ratio stands at 0.25, which is substantially lower than NABZY's P/B ratio of 1.57, suggesting that BKEAY is undervalued relative to its book value [6] Zacks Rank and Style Scores - BKEAY holds a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions, while NABZY has a Zacks Rank of 4 (Sell) [3] - BKEAY has earned a Value grade of A, contrasting with NABZY's Value grade of F, highlighting BKEAY's stronger position in terms of value metrics [6]
GILD vs. VRTX: Which Stock Is the Better Value Option?
ZACKS· 2025-03-13 17:09
Core Insights - Investors in the Medical - Biomedical and Genetics sector should consider Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) for potential value opportunities [1] Valuation Metrics - GILD has a forward P/E ratio of 14.49, while VRTX has a forward P/E of 28.07, indicating GILD may be undervalued compared to VRTX [5] - GILD's PEG ratio is 0.74, suggesting a favorable valuation when considering expected earnings growth, whereas VRTX's PEG ratio is 1.20 [5] - GILD's P/B ratio is 7.38, compared to VRTX's P/B of 7.78, further supporting GILD's stronger valuation metrics [6] Analyst Outlook - GILD currently holds a Zacks Rank of 2 (Buy), indicating a more favorable earnings estimate revision activity compared to VRTX, which has a Zacks Rank of 3 (Hold) [3][6] - The solid earnings outlook for GILD positions it as the superior value option in comparison to VRTX [6]
ABM vs. CTAS: Which Stock Is the Better Value Option?
ZACKS· 2025-03-06 17:45
Core Viewpoint - Investors in the Business - Services sector should consider ABM Industries and Cintas as potential undervalued stocks, with ABM currently appearing to be the superior value option based on various valuation metrics [1][6]. Valuation Metrics - Both ABM Industries and Cintas have a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and an improving earnings outlook for both companies [3]. - ABM has a forward P/E ratio of 14.13, significantly lower than Cintas's forward P/E of 47.58, suggesting that ABM may be undervalued relative to Cintas [5]. - The PEG ratio for ABM is 2.73, while Cintas has a PEG ratio of 3.96, further indicating that ABM is more favorably valued when considering expected earnings growth [5]. - ABM's P/B ratio stands at 1.85, compared to Cintas's P/B of 19.28, reinforcing the notion that ABM is a better value option [6]. - Based on these valuation figures, ABM earns a Value grade of A, while Cintas receives a Value grade of D, highlighting the relative undervaluation of ABM [6].
CON vs. MEDP: Which Stock Is the Better Value Option?
ZACKS· 2025-03-06 17:45
Core Viewpoint - The comparison between Concentra Group (CON) and Medpace (MEDP) indicates that CON presents a better value opportunity for investors at this time [1]. Group 1: Zacks Rank and Earnings Outlook - CON has a Zacks Rank of 2 (Buy), while MEDP has a Zacks Rank of 3 (Hold), suggesting that CON is likely experiencing a more favorable earnings outlook [3]. - The Zacks Rank focuses on companies with positive earnings estimate revisions, which is a key factor for value investors [2]. Group 2: Valuation Metrics - CON has a forward P/E ratio of 17.37, compared to MEDP's forward P/E of 26.73, indicating that CON may be undervalued relative to MEDP [5]. - The PEG ratio for CON is 2.08, while MEDP's PEG ratio is 3.63, further suggesting that CON has a more attractive valuation based on expected earnings growth [5]. - CON's P/B ratio is 10.37, whereas MEDP's P/B ratio is 12.37, reinforcing the notion that CON is more favorably valued [6]. Group 3: Value Grades - CON has a Value grade of B, while MEDP has a Value grade of C, indicating that CON is perceived as a better value investment [6].
Are Investors Undervaluing Everi (EVRI) Right Now?
ZACKS· 2025-03-06 15:45
Core Viewpoint - The article emphasizes the importance of value investing and highlights Everi (EVRI) as a strong candidate for value investors due to its favorable valuation metrics and earnings outlook [2][3][6]. Valuation Metrics - Everi has a Price-to-Book (P/B) ratio of 4.70, which is attractive compared to the industry average of 5.14. The P/B ratio has fluctuated between 2.32 and 4.73 over the past 52 weeks, with a median of 4.46 [4]. - The Price-to-Cash Flow (P/CF) ratio for Everi is 6.61, significantly lower than the industry average of 13.87. This ratio has ranged from 2.62 to 6.65 in the past year, with a median of 5.75 [5]. Investment Outlook - Everi holds a Zacks Rank of 2 (Buy) and an "A" grade in the Value category, indicating it is among the strongest value stocks currently available in the market [3][6].
PAYO vs. V: Which Stock Should Value Investors Buy Now?
ZACKS· 2025-03-03 17:47
Investors with an interest in Financial Transaction Services stocks have likely encountered both Payoneer Global Inc. (PAYO) and Visa (V) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis o ...
BDORY or UOVEY: Which Is the Better Value Stock Right Now?
ZACKS· 2025-02-27 17:40
Core Viewpoint - Investors in the Banks - Foreign sector should consider Banco Do Brasil SA (BDORY) and United Overseas Bank Ltd. (UOVEY) for potential value opportunities [1] Valuation Metrics - Banco Do Brasil SA has a Zacks Rank of 1 (Strong Buy), indicating a positive earnings outlook, while United Overseas Bank Ltd. has a Zacks Rank of 3 (Hold) [3] - BDORY has a forward P/E ratio of 4.34, significantly lower than UOVEY's forward P/E of 10.44, suggesting BDORY may be undervalued [5] - The PEG ratio for BDORY is 1.55, compared to UOVEY's PEG ratio of 1.81, indicating BDORY has a more favorable growth outlook relative to its valuation [5] - BDORY's P/B ratio is 0.81, while UOVEY's P/B ratio is 1.37, further supporting the argument that BDORY is undervalued [6] - Based on various valuation metrics, BDORY holds a Value grade of A, whereas UOVEY has a Value grade of C [6] Conclusion - BDORY has demonstrated stronger estimate revision activity and more attractive valuation metrics than UOVEY, making it a more appealing option for value investors [7]
PYPL vs. MA: Which Stock Is the Better Value Option?
ZACKS· 2025-02-26 17:45
Investors looking for stocks in the Financial Transaction Services sector might want to consider either Paypal (PYPL) or MasterCard (MA) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnings estimates an ...